申请人:Board of Regents, The University of Texas System
公开号:US20210094951A1
公开(公告)日:2021-04-01
Disclosed herein are compounds which inhibit RIPK1, pharmaceutical compositions, and methods of treatment of RIPK1-mediated diseases, such as neurodegenerative disorders, inflammatory disorders, and cancer.